3 April 2024 in Computers in Biology and Medicine
Latent diffusion models (LDMs) have emerged as a state-of-the-art image generation method, outperforming previous Generative Adversarial Networks (GANs) in terms of training stability and image quality. In computational pathology, generative models are valuable for data sharing and data augmentation. However, the impact of LDM-generated images on histopathology tasks compared to traditional GANs has not been systematically studied. We trained three LDMs and a styleGAN2 model on histology tiles from nine colorectal cancer (CRC) tissue classes. The LDMs include 1) a fine-tuned version of stable diffusion v1.4, 2) a Kullback-Leibler (KL)-autoencoder (KLF8-DM), and 3) a vector quantized (VQ)-autoencoder deploying LDM (VQF8-DM). We assessed image quality through expert ratings, dimensional reduction methods, distribution similarity measures, and their impact on training a multiclass tissue classifier. Additionally, we investigated image memorization in the KLF8-DM and styleGAN2 models. All models provided a high image quality, with the KLF8-DM achieving the best Frechet Inception Distance (FID) and expert rating scores for complex tissue classes. For simpler classes, the VQF8-DM and styleGAN2 models performed better. Image memorization was negligible for both styleGAN2 and KLF8-DM models. Classifiers trained on a mix of KLF8-DM generated and real images achieved a 4% improvement in overall classification accuracy, highlighting the usefulness of these images for dataset augmentation. Our systematic study of generative methods showed that KLF8-DM produces the highest quality images with negligible image memorization. The higher classifier performance in the generatively augmented dataset suggests that this augmentation technique can be employed to enhance histopathology classifiers for various tasks.
4 November 2026 in medizinische genetik
Newborn screening (NBS) enables early detection of inherited diseases but is largely limited to conditions with reliable biomarkers. Advances in genomics have therefore prompted pilot studies evaluating DNA sequencing as an expansion of NBS, termed genomic NBS (gNBS). This review summarizes evidence from international gNBS studies, focusing on methodological frameworks, screen-positive rates, and early clinical and psychosocial outcomes. Major initiatives demonstrate technical feasibility and actionable findings in up to 4 % of newborns in the reviewed studies, with even higher estimates reported in individual studies in the broader literature. Parental acceptance depends on high test validity, clinical actionability, and high-quality counseling. Key challenges include variant interpretation, management of uncertainty, infrastructure demands, and cost-benefit considerations. International experience highlights implications for Germany, including evidence-based disease selection, integration of sequencing into existing NBS infrastructures, robust consent models, and harmonized national pathways for reporting, follow-up, and data governance.